Health Cor Management, L.P. Bristol Myers Squibb CO Transaction History

Health Cor Management, L.P.

$106 Million
Q4 2022

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $24,605 - $14.5 Million	-189,270 Reduced 45.89%	223,150 $15.9 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $8.55 Million - $9.42 Million	-117,740 Reduced 22.21%	412,420 $31.8 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $78.3 Million - $93.9 Million	-1,274,390 Reduced 70.62%	530,160 $38.7 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $95.4 Million - $111 Million	-1,779,610 Reduced 49.65%	1,804,550 $113 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $125 Million - $146 Million	2,109,790 Added 143.1%	3,584,160 $212 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $91.3 Million - $99.4 Million	1,474,370 New	1,474,370 $98.5 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $77 Million - $86.6 Million	-1,297,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $67.7 Million - $76.7 Million	1,172,200 Added 934.02%	1,297,700 $80.5 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $53.8 Million - $59.6 Million	-937,000 Reduced 88.19%	125,500 $7.57 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $48.7 Million - $56.9 Million	888,140 Added 509.37%	1,062,500 $62.5 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $30.9 Million - $44.9 Million	-665,640 Reduced 79.24%	174,360 $9.72 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $13.7 Million - $17.8 Million	-277,710 Reduced 24.85%	840,000 $53.9 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $38.3 Million - $45.4 Million	-894,940 Reduced 44.47%	1,117,710 $56.7 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $89.8 Million - $99.3 Million	2,012,650 New	2,012,650 $91.3 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $13.3 Million - $15.8 Million	-294,490 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $23.8 Million - $30.9 Million	488,750 New	488,750 $27 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $9.47 Million - $12.3 Million	-194,260 Reduced 39.75%	294,490 $15.3 Million
Q3 2018 Nov 15, 2018	SELL	$55.19 - $62.25 $27 Million - $30.4 Million	-488,750 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $5.68 Million - $7.07 Million	-112,330 Reduced 18.69%	488,750 $27 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $11.8 Million - $13.5 Million	196,410 Added 48.54%	601,080 $38 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $6.8 Million - $7.42 Million	113,530 Added 38.99%	404,670 $24.8 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $16.1 Million - $18.6 Million	291,140	291,140 $18.6 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.

Account